v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Sales, net of returns and allowances $ 3,966,463 $ 12,555 $ 5,659,878 $ 26,854
Cost of sales 8,427,377 3,020,204 13,755,496 6,943,555
Gross loss (4,460,914) (3,007,649) (8,095,618) (6,916,701)
Operating expenses        
Selling, general and administrative 14,002,517 13,030,143 28,692,360 24,940,402
Research and development 5,059,745 5,027,061 12,284,594 9,038,995
Total operating expenses 19,062,262 18,057,204 40,976,954 33,979,397
Loss from operations (23,523,176) (21,064,853) (49,072,572) (40,896,098)
Interest income (expense), net 505,500 (95,419) 1,055,859 (2,318,709)
Loss before benefit for income taxes (23,017,676) (21,160,272) (48,016,713) (43,214,807)
Benefit for income taxes 0 0 0 0
Net loss $ (23,017,676) $ (21,160,272) $ (48,016,713) $ (43,214,807)
Net loss per share of common stock        
Basic (in usd per share) $ (0.12) $ (0.13) $ (0.27) $ (0.28)
Diluted (in usd per share) $ (0.12) $ (0.13) $ (0.27) $ (0.28)
Weighted average shares used in computing net loss per share of common stock        
Basic (in shares) 185,660,305 159,107,776 176,453,477 155,543,436
Diluted (in shares) 185,660,305 159,107,776 176,453,477 155,543,436

Source